Real-world evidence with apixaban for stroke prevention in patients with nonvalvular atrial fibrillation in Germany: a retrospective study (REASSESS)
Crossref DOI link: https://doi.org/10.1007/s11739-017-1624-x
Published Online: 2017-02-13
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Coleman, Craig Ian
Antz, Matthias
Funding for this research was provided by:
Bayer Pharma AG (NA)
License valid from 2017-02-13